Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Louvir logo — The New Way to 340B

Louvir

The New Way to 340B

Founded 2021 United States Chicago, United States 13 employees Analytics

General Information

Company Name Louvir
Founded Year 2021
Location United States Chicago, United States +1
Employees 13
Industries Analytics
Social

Get notified when Louvir moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Louvir

Louvir is a disruptive startup offering a groundbreaking solution for Federally Qualified Health Centers, Ryan White Clinics, and STI Grantees in the healthcare industry. The company's slogan, "The New Way to 340B," aptly captures its mission. Louvir prides itself on being the sole vendor-agnostic platform that continuously oversees the 340B Program, ensuring both cost savings and compliance. The startup's unique selling point lies in its ability to perform tasks traditionally done by highly trained analysts, incorporating FQHC best practices, compliance knowledge, and industry intelligence into its web-based algorithms. This approach allows Louvir to provide a comprehensive picture of the 340B program for individuals in various roles, from data analysts to Compliance Officers and CFOs. Louvir's platform furnishes a wealth of functional and meaningful program data points, along with advanced time series analysis, empowering users to make informed decisions and take strategic actions. Louvir's analytical capabilities extend to Manufacturer Analysis, offering comprehensive insights into the impact of manufacturer restrictions, and Inventory Analysis, which provides historic and trending prescribing and purchase data insights. Additionally, the startup offers Pharmacy and TPA Network Analysis, enabling real-time and historic prescribing trends and capture rates. These insights inform TPA and contract pharmacy network decisions. Finally, Financial Reporting features complete the package, allowing for the generation of automated financial statements tailored to the needs of financial departments. Founded in 2021 and headquartered in the United States, Louvir presents an attractive investment opportunity in the Analytics sector. As of now, specific details regarding the last investment and investors are not available.

Taxonomy: 340B Program, Healthcare Compliance, Pharmacy Network, Financial Reporting, FQHC, STI Grantees, Compliance Management, Inventory Management

No funding data available for Louvir yet.

Get notified when Louvir raises funding

FAQ About Louvir

The New Way to 340B
Louvir was founded in 2021.
Louvir is headquartered in Chicago, United States.
Louvir operates in the following industries: Analytics.
Louvir has approximately 13 employees.

We're actively collecting intelligence on Louvir .

Track Louvir to get notified

Don't just browse. Track.

Signal Tracker monitors Louvir and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes